Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Tandem Diabetes Care

Biotech & Life Sciences · San Diego, United States · Founded 2006 · IPO 2013 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.40B
Market cap · Apr/2026
Revenue
$1.01B
Latest reported FY

Investors

4 investors on Tandem Diabetes Care's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 4 investors entered at this stage
TPG
Delphi Ventures
TPG Biotech
Domain Associates

Global footprint

Where Tandem Diabetes Care has talent and traffic

AI talent share
0.3% of workforce is AI talent
(6 of 2,175 staff)
Core AI00%
Other AI60.28%
Non-AI workforce2,16999.72%
Web traffic by country
390K monthly visits
across markets
🇺🇸 United States66.3%
🇨🇦 Canada10.6%
🇬🇧 United Kingdom3.3%
🇿🇦 South Africa2%
🇮🇹 Italy1.9%
Top 5 markets shown

Patent intelligence

$109M patent portfolio · 164 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$109M
7.8% of market cap · 4.6× smaller than top peer Insulet ($502M)
164 active patent families
Where Tandem Diabetes Care innovates Biomedical engineeringInsulinDrug deliveryPancreatic hormonePharmaceutical drug
Below peer median on Strategic, Market

Quality vs same-sector peers

Tandem Diabetes Care on the five Patsnap quality dimensions

Tandem Diabetes Care in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Tandem Diabetes Care concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Tandem Diabetes Care and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Tandem Diabetes Care on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo